3,5-diphenyl-4-azatricyclo[5.2.1.0^2,6]deca-2,5,8-triene | 152904-72-8

• 分子结构分类: 有机化合物 - 苯丙烷和聚酮 - 二芳基庚烷
• 英文名称: 3,5-diphenyl-4-azatricyclo[5.2.1.0^2,6]deca-2,5,8-triene
• 英文别名: 1,3-diphenyl-4,7-dihydro-4,7-methano-2H-isoindole；3,5-Diphenyl-4-azatricyclo[5.2.1.02,6]deca-2,5,8-triene
• CAS: 152904-72-8
• 化学式: C₂₁H₁₇N
• 分子量: 283.373
• InChiKey: UGAHBQXITFMZQO-UHFFFAOYSA-N

计算性质

• 辛醇/水分配系数(LogP)：
  5
• 重原子数：
  22
• 可旋转键数：
  2
• 环数：
  5.0
• sp3杂化的碳原子比例：
  0.14
• 拓扑面积：
  15.8
• 氢给体数：
  1
• 氢受体数：
  0

反应信息

• 作为反应物：
  描述：

  3,5-diphenyl-4-azatricyclo[5.2.1.0^2,6]deca-2,5,8-triene 在 10percent Pd/C ammonium formate 作用下， 以 乙醇 为溶剂， 生成 1,3-diphenyl-4,7-methano-4,5,6,7-tetrahydro-2H-isoindole
  参考文献：
  名称：

  1,3-Diaryl-4,5,6,7-tetrahydro-2H-isoindole Derivatives:  A New Series of Potent and Selective COX-2 Inhibitors in Which a Sulfonyl Group Is Not a Structural Requisite

  摘要：

  Novel tetrahydro-2H-isoindoles have been prepared and evaluated as inhibitors of the COX-2 isoenzyme. A 1,S-diaryl substitution on the central polycyclic ring system and absence of a sulfonyl moiety are the two structural features of this chemical series. A short and easy synthetic pathway produced several derivatives which were shown to be potent and selective COX-2 vs COX-1 inhibitors (IC50 = 0.6-100 nM for COX-2, 100->1000 nM for COX-1). Structural modifications established that a bicyclic ring appended to the pyrrole nucleus and 4,4'-difluoro substitution on the phenyl rings were optimal for high inhibitory potency. Activity was confirmed in the human whole blood assay and subsequently in the murine air-pouch model in which in vivo PGE2 inhibitory activity was evaluated with respect to gastric tolerance (ED50 for inhibition of exudate PGE2 of 3 mg/kg and gastric PGEB of 20 mg/kg). Gastric tolerance was further assessed after administration to mice of high doses (up to 400 mg/kg) of the inhibitors by measurement of gastric damage. This panel of studies allowed selection of a number of tetrahydro-2H-isoindoles which were compared in the adjuvant-induced arthritis model. Compounds 32 and 37 showed the most potent activity with ED50 values for edema inhibition in the noninjected paw of 0.35 and 0.15 mg/kg/day, respectively, after oral administration. In addition, this interesting antiinflammatory profile was accompanied by a protective effect against arthritis-induced osteopenia, the decrease being 50% with a dose of 0.25 mg/kg/day.

  DOI：

  10.1021/jm990965x
• 作为产物：
  描述：

  (+/-)-2endo.3exo-dibenzoyl-norbornene-(5) 在 ammonium formate 作用下， 以 乙醇 为溶剂， 反应 47.0h， 以34%的产率得到3,5-diphenyl-4-azatricyclo[5.2.1.0^2,6]deca-2,5,8-triene
  参考文献：
  名称：

  Syntheses and Spectral Properties of Norbornadiene-Fused Heterocycles: 1,3-Diphenyl-4,7-dihydro-4,7-methanobenzo[c]thiophene, -4,7-methano-2H-isoindole, and -4,7-methanoisobenzofuran

  摘要：

  介绍了一种新型二苯基取代噻吩、吡咯和呋喃在 3 和 4 位与降冰片二烯融合的合成方法。通过与环己烯融合衍生物的光谱特性进行比较，讨论了这些分子的结构。降冰片二烯融合噻吩的单晶 X 射线结构分析以及相关化合物的 PM3 计算显示，降冰片二烯融合杂环的环连接处碳原子的键角是扭曲的。

  DOI：

  10.1246/bcsj.66.2707

文献信息

• Neighboring Group Participation by Heteroaromatic Rings: The Wagner–Meerwein Type Skeletal Rearrangement in the Electrophilic Addition Reactions of Norbornadiene-Fused Furans, Pyrroles, and Thiophenes
  作者：Tomoshige Kobayashi、Takeo Tsuzuki、Mayu Saitoh

  DOI：10.1246/bcsj.72.1597

  日期：1999.7

  The electrophilic addition reactions of norbornadiene-fused furans, pyrroles, and thiophenes with bromine, arenesulfenyl chlorides, or a triazoledione generally afforded skeletally rearranged adducts except for a dibenzoyl-substituted thiophene. The formations of the adducts are attributable to the neighboring group participation by five-membered heteroaromatic rings, accompanied by the formations

  降冰片二烯稠合的呋喃、吡咯和噻吩与溴、芳烃亚磺酰氯或三唑二酮的亲电加成反应通常提供骨架重排的加合物，但二苯甲酰基取代的噻吩除外。加合物的形成归因于五元杂芳环的相邻基团参与，伴随着桥连杂芳烃离子的形成和随后的 Wagner-Meewein 型骨架重排。
• Nouveaux derives de pyrrole leur procédé de preparation et les compositions pharmaceutiques qui les contiennent
  申请人：ADIR ET COMPAGNIE

  公开号：EP0921119A1

  公开（公告）日：1999-06-09

  Composés de formule (I) : dans laquelle : Rreprésente un atome d'hydrogène, un groupement alkyle, un groupement amino éventuellement substitué ou un groupement acyle (C1-C6) linéaire ou ramifié, R1, R2,identiques ou différents, représentent chacun indépendamment l'un de l'autre un groupement aryle, hétéroaryle ou cycloalkyle (C5-C7), chacun de ces groupements pouvant être éventuellement substitué, A,avec les atomes communs du pyrrole, représente un cycloalkyle (C3-C12), monocyclique ou bicyclique, saturé ou insaturé, un hétérocycle saturé de 5 à 7 chaînons contenant un ou deux atomes d'azote ou un oxa-7 bicyclo[2.2.1]heptane, chacun de ces cycles pouvant être éventuellement substitué, leurs isomères ainsi que leurs sels d'addition à un acide ou à une base pharmaceutiquement acceptable. Medicaments.

  式(I)化合物 其中： R 代表氢原子、烷基、任选取代的氨基或直链或支链（C1-C6）酰基、 R1 和 R2（可以相同或不同）各自独立地代表芳基、杂芳基或（C5-C7）环烷基，其中每个基团都有可能被任选取代、 A，连同吡咯的公共原子，代表饱和或不饱和、单环或双环（C3-C12）环烷基、含有一个或两个氮原子的饱和 5 至 7 元杂环或 7-氧杂双环[2.2.1]庚烷，其中每个环都可能被任选取代、 它们的异构体及其与药学上可接受的酸或碱的加成盐。 药物。
• US6063804A
  申请人：——

  公开号：US6063804A

  公开（公告）日：2000-05-16
• US6114360A
  申请人：——

  公开号：US6114360A

  公开（公告）日：2000-09-05
• 1,3-Diaryl-4,5,6,7-tetrahydro-2<i>H</i>-isoindole Derivatives:  A New Series of Potent and Selective COX-2 Inhibitors in Which a Sulfonyl Group Is Not a Structural Requisite
  作者：Bernard Portevin、Charles Tordjman、Philippe Pastoureau、Jacqueline Bonnet、Guillaume De Nanteuil

  DOI：10.1021/jm990965x

  日期：2000.11.1

  Novel tetrahydro-2H-isoindoles have been prepared and evaluated as inhibitors of the COX-2 isoenzyme. A 1,S-diaryl substitution on the central polycyclic ring system and absence of a sulfonyl moiety are the two structural features of this chemical series. A short and easy synthetic pathway produced several derivatives which were shown to be potent and selective COX-2 vs COX-1 inhibitors (IC50 = 0.6-100 nM for COX-2, 100->1000 nM for COX-1). Structural modifications established that a bicyclic ring appended to the pyrrole nucleus and 4,4'-difluoro substitution on the phenyl rings were optimal for high inhibitory potency. Activity was confirmed in the human whole blood assay and subsequently in the murine air-pouch model in which in vivo PGE2 inhibitory activity was evaluated with respect to gastric tolerance (ED50 for inhibition of exudate PGE2 of 3 mg/kg and gastric PGEB of 20 mg/kg). Gastric tolerance was further assessed after administration to mice of high doses (up to 400 mg/kg) of the inhibitors by measurement of gastric damage. This panel of studies allowed selection of a number of tetrahydro-2H-isoindoles which were compared in the adjuvant-induced arthritis model. Compounds 32 and 37 showed the most potent activity with ED50 values for edema inhibition in the noninjected paw of 0.35 and 0.15 mg/kg/day, respectively, after oral administration. In addition, this interesting antiinflammatory profile was accompanied by a protective effect against arthritis-induced osteopenia, the decrease being 50% with a dose of 0.25 mg/kg/day.